Comprehensive Analysis of the Intravenous Immunoglobulin Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Projected Compound Annual Growth Rate (CAGR) of the Intravenous Immunoglobulin Market from 2025 to 2034, and What Factors Influence It?
The market size for intravenous immunoglobulin has significantly expanded in the previous years. It’s projected to escalate from $14.66 billion in 2024 to $15.72 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The impressive growth during the historical period is a result of the treatment for primary immunodeficiency disorders, dealing with neurological disorders, the growth of the elderly population, advancements made in plasma fractionation methods, new indications in neurology, the therapy for infectious diseases, and therapy for pediatric immunodeficiency.
Strong expansion is anticipated in the intravenous immunoglobulin market in the upcoming years. It is predicted to reach a value of $22.01 billion by 2029, with a compound annual growth rate (CAGR) of 8.8%. Several factors are believed to contribute to this growth during the forecast period, including an increase in autoimmune disorders, continued immunological research, rising expenditure in healthcare, a surge in cancer diagnosis, development of new immunoglobulin products, and the implementation of personalized medicine. The forecast period will also witness primary immunodeficiency disorders (PIDD) treatment, swift technological breakthroughs, strategic alliances and partnerships, improvements in manufacturing procedures, neurological uses, hematological applications, and developments in immunotherapy as major trends.
Which Drivers Are Expected to Have the Greatest Impact on the intravenous immunoglobulin Market’s Growth?
The growth of the intravenous immunoglobulin market is predicted to be propelled by the rising elderly population. This demographic represents individuals aged 65 and above. As age advances, the immune system functions less effectively and a deficiency in antibodies occurs. Hence, the requirement for immunoglobulins to supply these essential antibodies arises. This triggers a growth in demand for intravenous immunoglobulins, subsequently boosting the intravenous immunoglobulin market. For instance, data from the Population Reference Bureau, a Kenyan Nonprofit organization, in January 2024, predicts that the American population aged 65 and over will increase from 58 million in 2022 to 82 million by 2050 – a 47% growth. The proportion of this age bracket within the total population is also expected to rise from 17% to 23% within the same timeframe. Consequently, the strengthening number of elderly individuals will influence the expansion of the intravenous immunoglobulin market.
Get Your Free Sample of the Global Intravenous Immunoglobulin Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp
Who Are the Leading Players Fueling Growth in the Intravenous Immunoglobulin Market?
Major companies operating in the intravenous immunoglobulin market are:
• Bio Products Laboratory Limited_x000D_
• Biotest AG_x000D_
• China Biologic Products Holdings Inc._x000D_
• CSL Behring_x000D_
• Grifols S.A._x000D_
What Are the Emerging Trends Shaping the Future of the Intravenous Immunoglobulin Market?
The intravenous immunoglobulin market is witnessing a surge in product innovation as a primary trend. To maintain their market standing, the leading companies are concentrating their efforts on the innovation of new products like liquid immune globulin formulations. These are developed for treating immunodeficiency diseases. For example, GC Pharma, a pharmaceutical company based in South Korea, launched Alyglo in December 2023. This is an FDA-approved sterile, ready-to-use liquid formulation containing 10% immunoglobulin G (IgG), providing 100 mg/mL of protein. At least 96% of this is human IgG derived from pooled human plasma. The product is specifically indicated for treating primary humoral immunodeficiency (PI) in adults, 17 years and older. This category includes conditions like congenital agammaglobulinemia, common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).
Get Instant Access to the Global Intravenous Immunoglobulin Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
What Are the Main Segments of the Intravenous Immunoglobulin Market, and How Are They Evolving?
The intravenous immunoglobulin market covered in this report is segmented –
1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications
4) By End-User: Hospitals, Clinics, Home Care
Subsegments:
1) By Immunoglobulin G (IgG): Normal IgG, Specific IgG
2) By Immunoglobulin M (IgM): Normal IgM, Specific IgM
3) By Immunoglobulin A (IgA): Normal IgA, Specific IgA
4) By Immunoglobulin E (IgE): Normal IgE, Specific IgE
5) By Immunoglobulin D (IgD): Normal IgD, Specific IgD
Which Regions Are Driving Growth in the Intravenous Immunoglobulin Market?
North America was the largest region in the intravenous immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Defining Features of the Intravenous Immunoglobulin Market?
Intravenous immunoglobulin refers to a therapy used for the treatment of immunodeficient people. It is administered in the form of intravenous infusion. Infusion liquid is made from immunoglobulins collected from healthy individuals and purified to eliminate any blood-borne infection or impurity.
Browse Through More Similar Reports By The Business Research Company:
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2024
Immunofluorescence Assay Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report
Immunoglobulins Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: